Streck CD-Chex TdT™ Plus Assay

Quality control material for evaluating intracellular and surface antigens including CD1a, CD2, CD4, CD5, CD7, CD8, CD34, cytoplasmic CD3 and nuclear TdT (Terminal deoxynucleotidyl transferase)

Manufacturer: Streck 213565

 View all options for this product

Catalog No. 23-285-545

  Check Availability
Add to Cart


    Product Type CD-Chex TdT™ Plus Assay
    Stability 90-day closed-vial stability
    For Use With (Equipment) BD Biosciences and Beckman Coulter flow cytometry systems
    Quantity 1 x 1mL

    CD-Chex TdT Plus is the only commercially-available flow cytometry control assayed for TdT, CD1a, CD34 and cCD3 in a single control. The assay provides percent positive values for each assayed marker on abnormal leukocytes and when stained with fluorescent antibodies and analyzed by flow cytometry, CD-Chex TdT Plus provides reference values for abnormal cells often found in certain types of hematopoietic neoplasms. Developed with light scatter characteristics similar to abnormal peripheral blood leukocytes often found in a hematolymphoid neoplastic patient sample.

    • Positive procedural flow cytometry control for TdT, CD1a, CD34 and cytoplasmic CD3
    • Exhibits abnormal peripheral blood characteristics
    • Monitors reagent staining, erythrocyte lysis, sample preparation, and instrument performance
    • Other assayed markers include CD2, CD4, CD5, CD7 and CD8 
    • Offers a high level of CD34
    • For BD Biosciences and Beckman Coulter™ flow cytometry systems

  • Description & Specifications

Related Products

Product Content Feedback

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit